RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-17.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.12B
AUM Growth
+$2.12B
(-23%)
Cap. Flow
-$60.6M
Cap. Flow
% of AUM
-2.86%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
150
New
6
Increased
39
Reduced
39
Closed
16
Top Buys
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$36.4M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$19.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$11.5M |
| 4 |
Neurocrine Biosciences
NBIX
|
$10.3M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$9.78M |
Top Sells
| 1 |
AbbVie
ABBV
|
$30.7M |
| 2 |
Molina Healthcare
MOH
|
$23.6M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$17.3M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$15.1M |
| 5 |
Elanco Animal Health
ELAN
|
$13.1M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Consumer Staples | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $150M | 7.09% | 603,100 +14,002 | +2% | +$3.49M |
|
|
WCG
2
DELISTED
Wellcare Health Plans, Inc.
WCG
| $92M | 4.34% | 389,500 +154,000 | +65% | +$36.4M |
|
3
Intuitive Surgical
ISRG
$170B
| $72.8M | 3.44% | 152,000 +10,600 | +7% | +$5.08M |
|
|
AMRN
4
Amarin Corp
AMRN
$311M
| $60.9M | 2.88% | 4,476,000 +151,000 | +3% | +$2.06M |
|
|
GWPH
5
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $58.4M | 2.76% | 599,500 +199,500 | +50% | +$19.4M |
|
6
HCA Healthcare
HCA
$94.5B
| $56.6M | 2.67% | 455,000 | – | – |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $56.3M | 2.66% | 788,600 +143,600 | +22% | +$10.3M |
|
8
Pacira BioSciences
PCRX
$1.2B
| $53.8M | 2.54% | 1,250,000 -42,479 | -3% | -$1.83M |
|
9
Encompass Health
EHC
$12.3B
| $44.7M | 2.11% | 725,000 +48,500 | +7% | +$2.99M |
|
|
TSRO
10
DELISTED
TESARO, Inc.
TSRO
| $44.7M | 2.11% | 601,700 -133,300 | -18% | -$9.9M |
|
|
11
Molina Healthcare
MOH
$9.8B
| $39.7M | 1.88% | 342,000 -203,000 | -37% | -$23.6M |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $35.7M | 1.68% | 327,000 +16,500 | +5% | +$1.8M |
|
|
LOXO
13
DELISTED
Loxo Oncology, Inc
LOXO
| $33.8M | 1.6% | 241,500 +38,519 | +19% | +$5.4M |
|
14
Vertex Pharmaceuticals
VRTX
$100B
| $33.6M | 1.59% | 203,000 +7,000 | +4% | +$1.16M |
|
15
Teleflex
TFX
$5.59B
| $33.6M | 1.59% | 130,000 +6,000 | +5% | +$1.55M |
|
16
iRhythm Technologies
IRTC
$5.46B
| $33.5M | 1.58% | 482,000 +2,000 | +0.4% | +$139K |
|
17
Boston Scientific
BSX
$156B
| $32.3M | 1.53% | 915,000 +115,000 | +14% | +$4.06M |
|
|
ONC
18
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $30.1M | 1.42% | 214,800 -200 | -0.1% | -$28.1K |
|
19
Edwards Lifesciences
EW
$47.8B
| $28.1M | 1.33% | 183,500 +3,500 | +2% | +$536K |
|
20
Stryker
SYK
$150B
| $28.1M | 1.32% | 179,000 | – | – |
|
21
Collegium Pharmaceutical
COLL
$1.22B
| $27.6M | 1.3% | 1,605,105 -44,995 | -3% | -$773K |
|
22
Penumbra
PEN
$10.6B
| $27.5M | 1.3% | 225,000 -10,200 | -4% | -$1.25M |
|
|
WMGI
23
DELISTED
Wright Medical Group Inc
WMGI
| $27.2M | 1.28% | 1,000,000 | – | – |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $27.2M | 1.28% | 241,000 -101,000 | -30% | -$11.4M |
|
25
Exact Sciences
EXAS
$8.98B
| $24.3M | 1.15% | 385,000 | – | – |
|